title: Reply to Talarico et al.'s comment: "Rate of serious infections in patients with rheumatoid arthritis receiving tumor necrosis factor (TNF)-alpha antagonist: a prospective observational study".
authors: Department of Rheumatology, Lapeyronie Hospital, University of Montpellier 1, 34295 Montpellier cedex 5, France. Electronic address: che.helene@yahoo.fr.
authors: Helene
authors: H
authors: Che
authors: Department of Rheumatology, Lapeyronie Hospital, University of Montpellier 1, 34295 Montpellier cedex 5, France.
authors: Cedric
authors: C
authors: Lukas
authors: Department of Rheumatology, Lapeyronie Hospital, University of Montpellier 1, 34295 Montpellier cedex 5, France.
authors: Jacques
authors: J
authors: Morel
authors: Department of Rheumatology, Lapeyronie Hospital, University of Montpellier 1, 34295 Montpellier cedex 5, France.
authors: Bernard
authors: B
authors: Combe
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006566:Herpesviridae Infections / Q000209:etiology*; D006801:Humans
chemical_list: D018501:Antirheumatic Agents
keywords: Anti-TNF alpha therapy; Infections; Rheumatoid arthritis